Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent. (Q39592152)
Jump to navigation
Jump to search
scientific article published on 14 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent. |
scientific article published on 14 February 2011 |
Statements
Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent (English)
Julian L Goggi
Lucy Allen
Jon Barnett
Matthew S Morrison
14 February 2011